The global virtual care market size was USD 11.49 billion in 2023, calculated at USD 15.19 billion in 2024 and is projected to surpass around USD 247.67 billion by 2034, expanding at a CAGR of 32.2% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Virtual Care Market
5.1. COVID-19 Landscape: Virtual Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Virtual Care Market, By Modality
8.1. Virtual Care Market, by Modality, 2024-2034
8.1.1. Real-time Virtual Health
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Remote Patient Monitoring
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Store and Forward
8.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Virtual Care Market, By Component
9.1. Virtual Care Market, by Component, 2024-2034
9.1.1. Services
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Hardware
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Software
9.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Virtual Care Market, By Delivery Mode
10.1. Virtual Care Market, by Delivery Mode, 2024-2034
10.1.1. Web/App-based
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Cloud-based
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. On-premises
10.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Virtual Care Market, By End-user
11.1. Virtual Care Market, by End-user, 2024-2034
11.1.1. Healthcare Providers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Patients
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Employer Groups and Government Organizations
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Payers
11.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Virtual Care Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Modality (2021-2034)
12.1.2. Market Revenue and Forecast, by Component (2021-2034)
12.1.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.1.4. Market Revenue and Forecast, by End-user (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Modality (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Modality (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Modality (2021-2034)
12.2.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.2.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Modality (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Modality (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Modality (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Modality (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Modality (2021-2034)
12.3.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.3.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Modality (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Modality (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Modality (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Modality (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Modality (2021-2034)
12.4.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.4.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Modality (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Modality (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Modality (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Modality (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Modality (2021-2034)
12.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Modality (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Modality (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-user (2021-2034)
Chapter 13. Company Profiles
13.1. AMD Global Telemedicine
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. American Well
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. BioTelemetry
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. GlobalMedia Group
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Koninklijke Philips
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Resideo Life Care Solutions
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Medtronic
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Teladoc Health
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. InTouch Technologies
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Vivify Health
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client